Showing results (4321-4330 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 26, 2014
Profiling cancer gene mutations in clinical formalin-fixed, paraffin-embedded colorectal tumor specimens using targeted next-generation sequencingLiangxuan Zhang, Liangjing Chen, Sachin Sah, et al.
The Oncologist|February 19, 2014
Incidence, risk factors, and management of infusion-related reactions in breast cancer patients receiving trastuzumabLisa M Thompson, Karen Eckmann, Bonnie L Boster, et al.
The Oncologist|April 23, 2017
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic SettingDaniele Generali, Filippo Montemurro, Roberto Bordonaro, et al.
The Oncologist|March 22, 2021
Safety, Efficacy, and Pharmacokinetics of Metatinib Tromethamine Tablet in Patients with Advanced Refractory Solid Tumors: A Phase I Clinical TrialKe Cheng, Xiao-Yu Li, Yu-Wen Zhou, et al.
The Oncologist|March 25, 2021
Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination with 5-Fluorouracil in the FOLFIRI RegimenAlessandro Passardi, Manlio Monti, Caterina Donati, et al.
The Oncologist|September 15, 2011
The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancerMarije E Hamaker, Bianca M Buurman, Barbara C van Munster, et al.
The Oncologist|January 28, 2012
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of careTheodoros P Vassilakopoulos, Gerassimos A Pangalis, Andreas Katsigiannis, et al.
The Oncologist|October 25, 2011
Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?Sandra Steffens, Viktor Grünwald, Kristina I Ringe, et al.
The Oncologist|January 12, 2012
Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapyRenata Duchnowska, Wojciech Biernat, Barbara Szostakiewicz, et al.
The Oncologist|January 14, 2012
Neoplasms associated with germline and somatic NF1 gene mutationsSachin Patil, Ronald S Chamberlain
Pageof 571